Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Feb;34(2):145–147. doi: 10.1136/gut.34.2.145

Molecular biology and gastric carcinoma.

P A Wright 1, G T Williams 1
PMCID: PMC1373957  PMID: 8432461

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Czerniak B., Herz F., Gorczyca W., Koss L. G. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer. 1989 Oct 1;64(7):1467–1473. doi: 10.1002/1097-0142(19891001)64:7<1467::aid-cncr2820640718>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  2. Czerniak B., Herz F., Koss L. G., Schlom J. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas. Cancer. 1987 Nov 15;60(10):2432–2436. doi: 10.1002/1097-0142(19871115)60:10<2432::aid-cncr2820601014>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. De Biasi F., Del Sal G., Hand P. H. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors. Int J Cancer. 1989 Mar 15;43(3):431–435. doi: 10.1002/ijc.2910430315. [DOI] [PubMed] [Google Scholar]
  4. Doyle C. T., O'Leary J. J. The search for the universal fixative or 'magic juice'. J Pathol. 1992 Apr;166(4):331–332. doi: 10.1002/path.1711660403. [DOI] [PubMed] [Google Scholar]
  5. Falck V. G., Gullick W. J. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol. 1989 Oct;159(2):107–111. doi: 10.1002/path.1711590204. [DOI] [PubMed] [Google Scholar]
  6. Fujita K., Ohuchi N., Yao T., Okumura M., Fukushima Y., Kanakura Y., Kitamura Y., Fujita J. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers. Gastroenterology. 1987 Dec;93(6):1339–1345. doi: 10.1016/0016-5085(87)90264-2. [DOI] [PubMed] [Google Scholar]
  7. Garewal H. S., Sampliner R., Liu Y., Trent J. M. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. Cancer Genet Cytogenet. 1989 Oct 15;42(2):281–286. doi: 10.1016/0165-4608(89)90096-4. [DOI] [PubMed] [Google Scholar]
  8. Hirayama D., Fujimori T., Satonaka K., Nakamura T., Kitazawa S., Horio M., Maeda S., Nagasako K. Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer. Hum Pathol. 1992 Jun;23(6):681–685. doi: 10.1016/0046-8177(92)90325-w. [DOI] [PubMed] [Google Scholar]
  9. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Kato Y., Yanagisawa A., Nakamura Y. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 1992 Jun 1;52(11):3231–3233. [PubMed] [Google Scholar]
  10. Isaacson P. Biopsy appearances easily mistaken for malignancy in gastrointestinal endoscopy. Histopathology. 1982 Jul;6(4):377–389. doi: 10.1111/j.1365-2559.1982.tb02735.x. [DOI] [PubMed] [Google Scholar]
  11. Jiang W., Kahn S. M., Guillem J. G., Lu S. H., Weinstein I. B. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene. 1989 Jul;4(7):923–928. [PubMed] [Google Scholar]
  12. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991 Dec 1;51(23 Pt 1):6304–6311. [PubMed] [Google Scholar]
  13. Kim J. H., Takahashi T., Chiba I., Park J. G., Birrer M. J., Roh J. K., De Lee H., Kim J. P., Minna J. D., Gazdar A. F. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst. 1991 Jul 3;83(13):938–943. doi: 10.1093/jnci/83.13.938. [DOI] [PubMed] [Google Scholar]
  14. Lemoine N. R., Jain S., Silvestre F., Lopes C., Hughes C. M., McLelland E., Gullick W. J., Filipe M. I. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer. 1991 Jul;64(1):79–83. doi: 10.1038/bjc.1991.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Martin H. M., Filipe M. I., Morris R. W., Lane D. P., Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer. 1992 Apr 1;50(6):859–862. doi: 10.1002/ijc.2910500604. [DOI] [PubMed] [Google Scholar]
  16. Müller W., Borchard F. Expression of transforming growth factor-alpha in gastric carcinoma and normal gastric mucosa cells. Cancer. 1992 Jun 15;69(12):2871–2875. doi: 10.1002/1097-0142(19920615)69:12<2871::aid-cncr2820691202>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  17. Nakatani H., Sakamoto H., Yoshida T., Yokota J., Tahara E., Sugimura T., Terada M. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res. 1990 Aug;81(8):707–710. doi: 10.1111/j.1349-7006.1990.tb02631.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nasim M. M., Thomas D. M., Alison M. R., Filipe M. I. Transforming growth factor alpha expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma--an immunohistochemical study. Histopathology. 1992 Apr;20(4):339–343. doi: 10.1111/j.1365-2559.1992.tb00991.x. [DOI] [PubMed] [Google Scholar]
  19. Ochi H., Douglass H. O., Jr, Sandberg A. A. Cytogenetic studies in primary gastric cancer. Cancer Genet Cytogenet. 1986 Aug;22(4):295–307. doi: 10.1016/0165-4608(86)90022-1. [DOI] [PubMed] [Google Scholar]
  20. Ohuchi N., Hand P. H., Merlo G., Fujita J., Mariani-Costantini R., Thor A., Nose M., Callahan R., Schlom J. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Cancer Res. 1987 Mar 1;47(5):1413–1420. [PubMed] [Google Scholar]
  21. Rodriguez E., Rao P. H., Ladanyi M., Altorki N., Albino A. P., Kelsen D. P., Jhanwar S. C., Chaganti R. S. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 1990 Oct 1;50(19):6410–6416. [PubMed] [Google Scholar]
  22. Sano T., Tsujino T., Yoshida K., Nakayama H., Haruma K., Ito H., Nakamura Y., Kajiyama G., Tahara E. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res. 1991 Jun 1;51(11):2926–2931. [PubMed] [Google Scholar]
  23. Tahara E., Yasui W., Taniyama K., Ochiai A., Yamamoto T., Nakajo S., Yamamoto M. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. Jpn J Cancer Res. 1986 Jun;77(6):517–522. [PubMed] [Google Scholar]
  24. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 1991 Jun 1;51(11):3056–3058. [PubMed] [Google Scholar]
  25. Tanimoto H., Yoshida K., Yokozaki H., Yasui W., Nakayama H., Ito H., Ohama K., Tahara E. Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(4):263–267. doi: 10.1007/BF02890427. [DOI] [PubMed] [Google Scholar]
  26. Theisinger B., Welter C., Seitz G., Rio M. C., Lathe R., Chambon P., Blin N. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer. 1991;27(6):770–773. doi: 10.1016/0277-5379(91)90186-h. [DOI] [PubMed] [Google Scholar]
  27. Tsuda T., Tahara E., Kajiyama G., Sakamoto H., Terada M., Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res. 1989 Oct 15;49(20):5505–5508. [PubMed] [Google Scholar]
  28. Uchino S., Tsuda H., Noguchi M., Yokota J., Terada M., Saito T., Kobayashi M., Sugimura T., Hirohashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992 Jun 1;52(11):3099–3102. [PubMed] [Google Scholar]
  29. Wright N. A., Poulsom R., Stamp G. W., Hall P. A., Jeffery R. E., Longcroft J. M., Rio M. C., Tomasetto C., Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol. 1990 Dec;162(4):279–284. doi: 10.1002/path.1711620402. [DOI] [PubMed] [Google Scholar]
  30. Yamada Y., Yoshida T., Hayashi K., Sekiya T., Yokota J., Hirohashi S., Nakatani K., Nakano H., Sugimura T., Terada M. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res. 1991 Nov 1;51(21):5800–5805. [PubMed] [Google Scholar]
  31. Yamamoto T., Hattori T., Tahara E. Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma. Pathol Res Pract. 1988 Nov;183(6):663–669. doi: 10.1016/S0344-0338(88)80050-5. [DOI] [PubMed] [Google Scholar]
  32. Yasui W., Hata J., Yokozaki H., Nakatani H., Ochiai A., Ito H., Tahara E. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer. 1988 Feb 15;41(2):211–217. doi: 10.1002/ijc.2910410209. [DOI] [PubMed] [Google Scholar]
  33. Yoshida K., Hamatani K., Koide H., Abe Y., Ikeda H., Tsuchiyama H., Nakayama E., Shiku H. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. Cancer Detect Prev. 1988;12(1-6):369–376. [PubMed] [Google Scholar]
  34. Yoshida K., Hamatani K., Koide H., Ikeda H., Nakamura N., Akiyama M., Tsuchiyama H., Nakayama E., Shiku H. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Cancer Res. 1988 Oct 1;48(19):5503–5509. [PubMed] [Google Scholar]
  35. Yoshida M. C., Wada M., Satoh H., Yoshida T., Sakamoto H., Miyagawa K., Yokota J., Koda T., Kakinuma M., Sugimura T. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4861–4864. doi: 10.1073/pnas.85.13.4861. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES